Access cutting-edge von willebrand disease treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access von willebrand disease specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related von willebrand disease treatment provided free
The main aim of the study is to check effectiveness, side effects, and tolerability of vonicog alfa (recombinant von Willebrand factor \[rVWF\]), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (\<)18 years of age) with severe hereditary von Willebrand disease (VWD). The participants will be treated with vonicog alfa for 12-18 months. Their von Willebrand Disease will be treated by their doctor according to their doctor's
Sponsor: Baxalta now part of Shire
Check if you qualify for this von willebrand disease clinical trial in Omaha, NE
If you're searching for von willebrand disease treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced von willebrand disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.